PPAR Gamma and Angiogenesis: Endothelial Cells Perspective

The real face of endothelial progenitor cells – Circulating angiogenic cells as endothelial prognostic marker?

(2015) Neli Kachamakova-Trojanowska et al.   Pharmacological Reports

Ligands for the Nuclear Peroxisome Proliferator-Activated Receptor Gamma

(2015) Sascha Sauer   TRENDS IN PHARMACOLOGICAL SCIENCES

The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis

(2014) C M Werner et al.   BRITISH JOURNAL OF PHARMACOLOGY

The multifaceted activity of VEGF in angiogenesis – Implications for therapy responses

(2014) Stijn Moens et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Inhibition of HDAC3 promotes ligand-independent PPARγ activation by protein acetylation

(2014) Xiaoting Jiang et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Heme Oxygenase-1 Is Required for Angiogenic Function of Bone Marrow-Derived Progenitor Cells: Role in Therapeutic Revascularization

(2013) Anna Grochot-Przeczek et al.   ANTIOXIDANTS & REDOX SIGNALING

Nrf2 Regulates Angiogenesis: Effect on Endothelial Cells, Bone Marrow-Derived Proangiogenic Cells and Hind Limb Ischemia

(2013) Urszula Florczyk et al.   ANTIOXIDANTS & REDOX SIGNALING

Anti-angiogenesis in cancer therapy: Hercules and hydra

(2013) S. Bellou et al.   CANCER LETTERS

PPAR-γ agonist pioglitazone prevents apoptosis of endothelial progenitor cells from rat bone marrow

(2013) Hui-Feng Zhang et al.   CELL BIOLOGY INTERNATIONAL

Molecular Signatures of Tissue-Specific Microvascular Endothelial Cell Heterogeneity in Organ Maintenance and Regeneration

(2013) Daniel J. Nolan et al.   DEVELOPMENTAL CELL

Endothelial progenitor cell: a blood cell by many other names may serve similar functions

(2013) Mervin C. Yoder   JOURNAL OF MOLECULAR MEDICINE-JMM

Neovascularization in diabetes and its complications. Unraveling the angiogenic paradox

(2013) Paulo Zoé Costa et al.   LIFE SCIENCES

PPARγ signaling and metabolism: the good, the bad and the future

(2013) Maryam Ahmadian et al.   NATURE MEDICINE

Number of circulating pro-angiogenic cells, growth factor and anti-oxidative gene profiles might be altered in type 2 diabetes with and without diabetic foot syndrome

(2013) Witold N Nowak et al.   Journal of Diabetes Investigation

Critical Reevaluation of Endothelial Progenitor Cell Phenotypes for Therapeutic and Diagnostic Use

(2012) Gian Paolo Fadini et al.   CIRCULATION RESEARCH

Effect of rosiglitazone on capillary density and angiogenesis in adipose tissue of normoglycaemic humans in a randomised controlled trial

(2012) O. Gealekman et al.   DIABETOLOGIA

Pioglitazone Improves In Vitro Viability and Function of Endothelial Progenitor Cells from Individuals with Impaired Glucose Tolerance

(2012) Valentina Spigoni et al.   PLoS One

Pioglitazone activates aortic telomerase and prevents stress-induced endothelial apoptosis

(2011) Christian Werner et al.   ATHEROSCLEROSIS

Evidence Implicating Peroxisome Proliferator-Activated Receptor-γ in the Pathogenesis of Preeclampsia

(2011) Fergus P. McCarthy et al.   HYPERTENSION

Aldosterone inhibits endothelial morphogenesis and angiogenesis through the downregulation of vascular endothelial growth factor receptor-2 expression subsequent to peroxisome proliferator-activated receptor gamma

(2011) Miki Fujii et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Anti-angiogenic action of PPARγ ligand in human umbilical vein endothelial cells is mediated by PTEN upregulation and VEGFR-2 downregulation

(2011) Ki Young Kim et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

From Vessel Sprouting to Normalization

(2010) Cathy Coulon et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

PPARγ in Placental Angiogenesis

(2010) Karim Nadra et al.   ENDOCRINOLOGY

Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects

(2010) I. Zachary et al.   HEART

Endothelial progenitor cells: Quo Vadis?

(2010) Matthew R. Richardson et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Disruption of endothelial peroxisome proliferator-activated receptor-γ reduces vascular nitric oxide production

(2009) Jennifer M. Kleinhenz et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art

(2009) Irina Arnaoutova et al.   ANGIOGENESIS

Rosiglitazone via upregulation of Akt/eNOS pathways attenuates dysfunction of endothelial progenitor cells, induced by advanced glycation end products

(2009) Chun Liang et al.   BRITISH JOURNAL OF PHARMACOLOGY

Pioglitazone enhances collateral blood flow in ischemic hindlimb of diabetic mice through an Akt-dependent VEGF-mediated mechanism, regardless of PPARγ stimulation

(2009) Federico Biscetti et al.   Cardiovascular Diabetology

PPARα and PPARγ attenuate HIV-induced dysregulation of tight junction proteins by modulations of matrix metalloproteinase and proteasome activities

(2009) Wen Huang et al.   FASEB JOURNAL

Troglitazone Inhibits Vascular Endothelial Growth Factor–Induced Angiogenic Signaling via Suppression of Reactive Oxygen Species Production and Extracellular Signal–Regulated Kinase Phosphorylation in Endothelial Cells

(2009) Byung Chul Park et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

Effect of PPARγ inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension

(2009) Jing Tian et al.   PHYSIOLOGICAL GENOMICS

Effects of a PPAR-gamma agonist, on growth factor and insulin stimulated endothelial cells

(2009) Cyrus V. Desouza et al.   VASCULAR PHARMACOLOGY

PPARγ ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis

(2008) Ahmad Aljada et al.   ANGIOGENESIS

Vascular repair by endothelial progenitor cells

(2008) A. Zampetaki et al.   CARDIOVASCULAR RESEARCH

Selective Activation of Peroxisome Proliferator-Activated Receptor (PPAR)  and PPAR  Induces Neoangiogenesis Through a Vascular Endothelial Growth Factor-Dependent Mechanism

(2008) F. Biscetti et al.   DIABETES

Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth

(2008) S. Purhonen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA